4.8 Article

Reverse inflammaging: Long-term effects of HCV cure on biological age

期刊

JOURNAL OF HEPATOLOGY
卷 78, 期 1, 页码 90-98

出版社

ELSEVIER
DOI: 10.1016/j.jhep.2022.08.042

关键词

Hepatitis C virus; epigenetic age; direct-acting antiviral; sustained virological response; cirrhosis; Inflammaging; DNA methylation

向作者/读者索取更多资源

This study investigates the association between chronic hepatitis C virus (HCV) infection and epigenetic changes and biological age acceleration, as well as the reversibility of these changes after sustained virologic response (SVR). The results show that patients with chronic HCV infection have significant epigenetic age acceleration, which partially reverses after SVR. However, some patients still show incomplete reversal of biological age after treatment.
Background & Aims: Chronic hepatitis C virus (HCV) infection can be cured with direct-acting antivirals (DAAs). However, not all sequelae of chronic hepatitis C appear to be completely reversible after sustained virologic response (SVR). Recently, chronic viral infections have been shown to be associated with biological age acceleration defined by the epigenetic clock. The aim of this study was to investigate whether chronic HCV infection is associated with epigenetic changes and biological age acceleration and whether this is reversible after SVR.Methods: We included 54 well-characterized individuals with chronic hepatitis C who achieved SVR after DAA therapy at three time points: DAA treatment initiation, end of treatment, and long-term follow-up (median 96 weeks after end of treatment). Genome-wide DNA methylation status was determined in peripheral blood mononuclear cells (PBMCs) and used to calculate epigenetic age acceleration (EAA) using Horvath's clock.Results: Individuals with HCV had an overall significant EAA of 3.12 years at baseline compared with-2.61 years in the age-and sex-matched reference group (p <0.00003). HCV elimination resulted in a significant long-term increase in DNA methylation dominated by hypermethylated CpGs in all patient groups. Accordingly, EAA decreased to 1.37 years at long-term follow-up. The decrease in EAA was significant only between the end of treatment and follow-up (p = 0.01). Interestingly, eight individuals who developed hepatocellular carcinoma after SVR had the highest EAA and showed no evidence of reversal after SVR.Conclusions: Our data contribute to the understanding of the biological impact of HCV elimination after DAA therapy and demonstrate that HCV elimination can lead to reverse inflammaging. In addition, our data support the potential use of biological age as a biomarker for HCV sequelae after SVR.(c) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据